Bellevue Life Sciences Acquisition Corp. (BLAC) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 28 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Mar 23, 2023 involved a transaction of 20,000 shares valued at $0.
No significant insider buying has been recorded for BLAC in the recent period.
No significant insider selling has been recorded for BLAC in the recent period.
Based on recent SEC filings, insider sentiment for BLAC is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
Insider trading at Bellevue Life Sciences Acquisition Corp. (BLAC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading BLAC stock, having executed 28 transactions in the past 90 days. The most active insider is Global Life Science Investors Llc Bellevue (Executive), who has made 11 transactions totaling $4.3M.
Get notified when executives and directors at BLAC file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 23, 2023 | Life Science Investors Llc Bellevue Global | Executive | Other | 20,000 | $N/A | $0 | |
| Mar 23, 2023 | Jin Yoo David | Executive | Award | 20,000 | $N/A | $0 | |
| Mar 23, 2023 | Hyoun Hwang Kuk | Executive | Other | 20,000 | $N/A | $0 | |
| Feb 21, 2023 | Life Science Investors Llc Bellevue Global | Executive | Other | 4,500 | $N/A | $0 | |
| Feb 21, 2023 | Life Science Investors Llc Bellevue Global | Executive | Other | 225,000 | $N/A | $0 | |
| Feb 21, 2023 | Hyoun Hwang Kuk | Executive | Other | 4,500 | $N/A | $0 | |
| Feb 21, 2023 | Hyoun Hwang Kuk | Executive | Other | 225,000 | $N/A | $0 | |
| Feb 14, 2023 | Hyoun Hwang Kuk | Executive | Other | 30,000 | $N/A | $0 | |
| Feb 14, 2023 | Hyoun Hwang Kuk | Executive | Other | 225,000 | $N/A | $0 | |
| Feb 14, 2023 | Hyoun Hwang Kuk | Executive | Other | 20,000 | $N/A | $0 | |
| Feb 14, 2023 | Hyoun Hwang Kuk | Executive | Award | 430,000 | $10.00 | $4.3M | Large |
| Feb 14, 2023 | Hyoun Hwang Kuk | Executive | Other | 20,000 | $N/A | $0 | |
| Feb 14, 2023 | Hyoun Hwang Kuk | Executive | Other | 20,000 | $N/A | $0 | |
| Feb 14, 2023 | Hyoun Hwang Kuk | Executive | Other | 20,000 | $N/A | $0 | |
| Feb 14, 2023 | Hyoun Hwang Kuk | Executive | Other | 20,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 8 | $8.6M | 100.0% |
Other(J) | 20 | $0 | 0.0% |
Insider activity at Bellevue Life Sciences Acquisition Corp. shows mixed signals across all time. While $0 in purchases indicates some executive confidence,$0 in sales balances the picture, resulting in a modest net flow of $0.8 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Global Life Science Investors Llc Bellevue, has transacted $4.3M during this period.